Pancreatic Cancer | Philip Philip, MD, PhD, FRCP

published 1 month ago by Dr Neil Love

Data + Perspectives: Clinical Investigators Explore the Biology Underlying the Role of PARP Inhibition in the Management of Common Cancers — Faculty Presentation 3: PARP inhibitors in pancreatic cancer — Dr Philip. CME information and select publications

more episodes from Research To Practice | Oncology Videos